Amylyx Pharmaceuticals(AMLX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

AMLX Amylyx Pharmaceuticals

Trading 11-11 10:24:31 EST

30.89

-0.02

-0.06%

High31.27	Low30.46	Vol100.49K
Open31.16	D1 Closing30.91	Amplitude2.62%
Mkt Cap3.97B	Tradable Cap3.49B	Total Shares128.56M
T/O3.11M	T/O Rate0.09%	Tradable Shares113.00M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"AMLX","market":"US","secType":"STK","nameCN":"Amylyx Pharmaceuticals","latestPrice":30.89,"timestamp":1794410668009,"preClose":30.91,"halted":0,"volume":100489,"delay":0,"changeRate":-0.0006470397929472524,"floatShares":112999999,"shares":128562904,"eps":-1.451637,"marketStatus":"Trading","change":-0.02,"latestTime":"11-11 10:24:31 EST","open":31.16,"high":31.27,"low":30.46,"amount":3113193.636138,"amplitude":0.026205,"askPrice":31.01,"askSize":206,"bidPrice":30.89,"bidSize":201,"shortable":3,"etf":0,"ttmEps":-1.451637,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1794430800000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1641531600000,"exchange":"NASDAQ","adjPreClose":30.91,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":31.15,"preClose":30.91,"latestTime":"09:23 EST","volume":541,"amount":16836.30952,"timestamp":1794407015122,"change":0.24,"changeRate":0.007764,"amplitude":0.069557},"postHourTrading":{"tag":"盘后","latestPrice":30.91,"preClose":30.91,"latestTime":"19:30 EST","volume":8337,"amount":257681.91,"timestamp":1794357004761,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.425181,"impliedVol":0.5354,"impliedVolPercentile":0.2749},"requestUrl":"/m/hq/s/AMLX","defaultTab":"news","newsList":[{"id":"2682047328","title":"1414 Degrees outlines Aurora ownership and technology activities","url":"https://stock-news.laohu8.com/highlight/detail?id=2682047328","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2682047328?lang=en_us&edition=fundamental","pubTime":"2026-11-11 08:49","pubTimestamp":1794358141,"startTime":"0","endTime":"0","summary":"The latest announcement is out from 1414 Degrees Ltd. ( ($AU:14D) ). 1414 Degrees operates across energy infrastructure, advanced battery materials...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/1414-degrees-outlines-aurora-ownership-and-technology-activities?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/1414-degrees-outlines-aurora-ownership-and-technology-activities?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["WBAT","BKGI","HALX","ASET","ABLD","IDRV","NML","USAI","EIPX","IGF","TBG","EIPI","RIFR","GLIX","ALTY","EART","MLPR","TINT","ACB","CARZ","BATT","GSFP","NFRX","XLEI","AMZA","DIV","VRAI","CLNR","ENFR","ARKG","PPI","EVAV","AMLP","HIPS","NFRA","UMI","TOLZ","IBAT","IMLP","SMOG","IQRA","DRIV","MLPB","GII","MDIV","AMLX","WEEI","MLPI","DFRA","EINC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682317693","title":"Amylyx Pharmaceuticals is Maintained at Outperform by Mizuho","url":"https://stock-news.laohu8.com/highlight/detail?id=2682317693","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2682317693?lang=en_us&edition=fundamental","pubTime":"2026-11-11 01:46","pubTimestamp":1794332760,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/AMLX/analyst-ratings","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","LU0053671581.USD","BK4007","LU0889565916.HKD","LU0109394709.USD","AMLX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682336288","title":"U.S. Market Rallies into the Close as Oil Prices Fall and Tech Stocks Rebound","url":"https://stock-news.laohu8.com/highlight/detail?id=2682336288","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2682336288?lang=en_us&edition=fundamental","pubTime":"2026-11-10 05:01","pubTimestamp":1794258102,"startTime":"0","endTime":"0","summary":"U.S. equities surged into the close on Nov. 9, lifted higher by a sharp pullback in crude oil prices and a rebound in technology stocks to start th...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/u-s-market-rallies-into-the-close-as-oil-prices-fall-and-tech-stocks-rebound?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/u-s-market-rallies-into-the-close-as-oil-prices-fall-and-tech-stocks-rebound?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EDGH","COM","DTO","DUG","BCI","DCMT","OIH","DJP","BWET","AVIE","DIG","XLE","DBO","CMDT","XOP","USOI","BNO","WTIU","UGA","OILT","XES","VDE","USO","GUSH","CRAK","OILU","DBE","BCD","CMCI","COMT","DWT","DBC","IEO","OILK","AMLX","CERY","CCRV","ERX","USL","BPH","USE","CMDY","PXJ","DRIP","COLO","FTXN","PXE","XLK","DRLL","IXC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682385992","title":"Mizuho Adjusts Price Target on Amylyx Pharmaceuticals to $39 From $38, Maintains Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2682385992","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2682385992?lang=en_us&edition=fundamental","pubTime":"2026-11-09 21:15","pubTimestamp":1794230143,"startTime":"0","endTime":"0","summary":"Amylyx Pharmaceuticals (AMLX) has an average rating of buy and mean price target of $43, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0889565916.HKD","BK4007","LU0109394709.USD","LU0320765992.SGD","LU0053671581.USD","AMLX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682382329","title":"Amylyx Pharmaceuticals (AMLX) Stock Still Trades At A Premium As Phase 3 Progress Advances","url":"https://stock-news.laohu8.com/highlight/detail?id=2682382329","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2682382329?lang=en_us&edition=fundamental","pubTime":"2026-11-09 00:18","pubTimestamp":1794154716,"startTime":"0","endTime":"0","summary":"SSasha JovanovicNovember 8, 2026","market":"sg","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=240/https://images.simplywall.st/asset/industry/6121000-choice2-card/1788952923351","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=240/https://images.simplywall.st/asset/industry/6121000-choice2-card/1788952923351"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-amlx/amylyx-pharmaceuticals/news/amylyx-pharmaceuticals-amlx-stock-still-trades-at-a-premium","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-amlx/amylyx-pharmaceuticals/news/amylyx-pharmaceuticals-amlx-stock-still-trades-at-a-premium","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["AMLX","LU0889565916.HKD","PRGS","BK4007","LU0109394709.USD","LU0053671581.USD","LU0320765992.SGD","LU2065732104.USD","BK4097"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681981058","title":"Amylyx Stock Has The Bull Case Changed After Phase III Trial Success","url":"https://stock-news.laohu8.com/highlight/detail?id=2681981058","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681981058?lang=en_us&edition=fundamental","pubTime":"2026-11-07 22:22","pubTimestamp":1794061360,"startTime":"0","endTime":"0","summary":"BBailey PembertonNovember 7, 2026","market":"hk","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=240/https://images.simplywall.st/asset/industry/6121000-choice2-card/1788952923351","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=240/https://images.simplywall.st/asset/industry/6121000-choice2-card/1788952923351"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-amlx/amylyx-pharmaceuticals/news/amylyx-stock-has-the-bull-case-changed-after-phase-iii-trial","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-amlx/amylyx-pharmaceuticals/news/amylyx-stock-has-the-bull-case-changed-after-phase-iii-trial","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0889565916.HKD","LU0053671581.USD","BK4007","LU0320765992.SGD","AMLX","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681864049","title":"Amylyx Pharmaceuticals (AMLX) Reports Positive Phase 3 Data, Is The Stock Still 35% Undervalued?","url":"https://stock-news.laohu8.com/highlight/detail?id=2681864049","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681864049?lang=en_us&edition=fundamental","pubTime":"2026-11-06 21:37","pubTimestamp":1793972225,"startTime":"0","endTime":"0","summary":"SSasha JovanovicNovember 6, 2026","market":"hk","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=240/https://images.simplywall.st/asset/industry/6121000-choice2-card/1788952923351","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=240/https://images.simplywall.st/asset/industry/6121000-choice2-card/1788952923351"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-amlx/amylyx-pharmaceuticals/news/amylyx-pharmaceuticals-amlx-reports-positive-phase-3-data-is","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-amlx/amylyx-pharmaceuticals/news/amylyx-pharmaceuticals-amlx-reports-positive-phase-3-data-is","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0053671581.USD","LU0320765992.SGD","BK4007","LU0889565916.HKD","LU0109394709.USD","AMLX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681835035","title":"APA raises EUR550 million to refinance debt","url":"https://stock-news.laohu8.com/highlight/detail?id=2681835035","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681835035?lang=en_us&edition=fundamental","pubTime":"2026-11-06 12:07","pubTimestamp":1793938074,"startTime":"0","endTime":"0","summary":"APA Group ( ($AU:APA) ) has shared an update. APA Group is an ASX-listed Australian energy infrastructure business operating gas transmission, proc...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/apa-raises-eur550-million-to-refinance-debt?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/apa-raises-eur550-million-to-refinance-debt?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MLPR","NFRX","VRAI","DBE","USAI","FTXN","PPI","DFRA","WTIU","ABLD","IQRA","RIFR","DRIP","IGF","MDIV","ENFR","GUSH","EIPX","NFRA","AMLX","DIG","TBG","UMI","VDE","DRLL","PXE","AMZA","TOLZ","ERX","BKGI","HALX","AMLP","GII","WEEI","IEO","MLPB","XES","USE","DBC","NML","GLIX","DIV","EINC","PXJ","EIPI","ASET","IXC","XLEI","ALTY","HIPS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681881220","title":"Amylyx Earnings Call Highlights Avexitide’s 2027 Launch Path","url":"https://stock-news.laohu8.com/highlight/detail?id=2681881220","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681881220?lang=en_us&edition=fundamental","pubTime":"2026-11-06 08:14","pubTimestamp":1793924088,"startTime":"0","endTime":"0","summary":"Amylyx Pharmaceuticals, Inc. (($AMLX)) has held its Q3 earnings call. Read on for the main highlights of the call. Amylyx Pharmaceuticals delivered...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/amylyx-earnings-call-highlights-avexitides-2027-launch-path?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/amylyx-earnings-call-highlights-avexitides-2027-launch-path?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PMDE","JOYT","BK4007","LU0320765992.SGD","LU0889565916.HKD","DECU","LU0053671581.USD","AMLX","GXDW","VOTE","VGFPF","RGLO","LU0109394709.USD","FEBU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681307215","title":"Amylyx Pharmaceuticals, Inc. Reports Results for the Quarter Ended September 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2681307215","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681307215?lang=en_us&edition=fundamental","pubTime":"2026-11-05 23:16","pubTimestamp":1793891797,"startTime":"0","endTime":"0","summary":"Amylyx Pharmaceuticals, Inc. reports results for the quarter ended September 30 - Earnings SummaryAmylyx Pharmaceuticals, Inc.AMLX.OQreported a quarterly adjusted loss of 38 cents per share for the qu","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261105:nL5N46M261:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0053671581.USD","LU0109394709.USD","BK4007","AMLX","LU0889565916.HKD","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681027523","title":"Earnings Flash (AMLX) Amylyx Pharmaceuticals Posts Q3 Loss $0.38 a Share, vs. FactSet Est of $0.37 Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2681027523","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681027523?lang=en_us&edition=fundamental","pubTime":"2026-11-05 20:17","pubTimestamp":1793881050,"startTime":"0","endTime":"0","summary":"Earnings Flash (AMLX) Amylyx Pharmaceuticals Posts Q3 Loss $0.38 a Share, vs. FactSet Est of $0.37 Loss","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AMLX","LU0109394709.USD","LU0889565916.HKD","BK4007","LU0053671581.USD","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681851027","title":"Amylyx Pharma Q3 Net Loss Bigger than Expected","url":"https://stock-news.laohu8.com/highlight/detail?id=2681851027","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681851027?lang=en_us&edition=fundamental","pubTime":"2026-11-05 20:15","pubTimestamp":1793880929,"startTime":"0","endTime":"0","summary":"Amylyx Pharma Q3 net loss bigger than expectedOverviewU.S. biopharma's Q3 loss per share was in line with analyst expectationsNet loss and operating income for Q3 missed analyst estimatesCompany repor","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261105:nL2N46M0OC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2488822045.USD","LU0320765992.SGD","BK4007","KLRA","LU0109394709.USD","LU0889565916.HKD","BK4139","OZEM","LU0053671581.USD","AMLX","SMMT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681502296","title":"Amylyx Q3 Net Loss Widens 32% Year over Year to $45.49 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2681502296","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681502296?lang=en_us&edition=fundamental","pubTime":"2026-11-05 20:07","pubTimestamp":1793880439,"startTime":"0","endTime":"0","summary":"Amylyx Q3 net loss widens 32% year over year to $45.49 millionAmylyx Pharmaceuticals’ third-quarter 2026 net loss widened 32% year over year to $45.49 million.Cash, cash equivalents and marketable sec","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261105:nNDL3JqlBw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0053671581.USD","LU0889565916.HKD","AMLX","LU0320765992.SGD","LU0109394709.USD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681002288","title":"Amylyx Pharmaceuticals Q3 EPS USD -0.38 Vs. IBES Estimate USD -0.38","url":"https://stock-news.laohu8.com/highlight/detail?id=2681002288","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681002288?lang=en_us&edition=fundamental","pubTime":"2026-11-05 20:01","pubTimestamp":1793880061,"startTime":"0","endTime":"0","summary":"BRIEF-Amylyx Pharmaceuticals Q3 EPS USD -0.38 Vs. IBES Estimate USD -0.38Nov 05  - Amylyx Pharmaceuticals Q3 operating expenses USD 49.658 million.Q3 net income USD -45.489 million vs. IBES estimate USD -43.7 millionQ3 operating income USD -49.658 million vs. IBES estimate USD -46.2 million","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261105:nPLXGHHHMS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","AMLX","BK4007","LU0109394709.USD","LU0053671581.USD","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681728024","title":"Amylyx Pharma Q3 EPS $(0.38), Inline","url":"https://stock-news.laohu8.com/highlight/detail?id=2681728024","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681728024?lang=en_us&edition=fundamental","pubTime":"2026-11-05 20:00","pubTimestamp":1793880042,"startTime":"0","endTime":"0","summary":"Amylyx Pharma (NASDAQ:AMLX) reported quarterly losses of $(0.38) per share which met the analyst consensus estimate. This is a 2.7 percent decrease over losses of $(0.37) per share from the same period last year.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/11/62910719/amylyx-pharma-q3-eps-0-38-inline","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","AMLX","LU0109394709.USD","LU0053671581.USD","LU0889565916.HKD","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680393057","title":"Amylyx Hosts Investor Event to Discuss Phase 3 Avexitide Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2680393057","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680393057?lang=en_us&edition=fundamental","pubTime":"2026-11-04 22:06","pubTimestamp":1793801200,"startTime":"0","endTime":"0","summary":"Amylyx Hosts Investor Event to Discuss Phase 3 Avexitide ResultsAmylyx Pharmaceuticals will host an investor event at ObesityWeek in Washington, D.C., on November 15, 2026, at 11:45 a.m. ET.The in-per","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261104:nNDL4mJ56R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","AMLX","BK4007","LU0053671581.USD","LU0889565916.HKD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680089144","title":"APA Group Issues 1.11 Million Unquoted Performance Rights","url":"https://stock-news.laohu8.com/highlight/detail?id=2680089144","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680089144?lang=en_us&edition=fundamental","pubTime":"2026-11-04 13:47","pubTimestamp":1793771244,"startTime":"0","endTime":"0","summary":"The latest update is out from APA Group ( ($AU:APA) ). APA Group is an Australian energy infrastructure company focused on owning and operating gas...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/apa-group-issues-1-11-million-unquoted-performance-rights?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/apa-group-issues-1-11-million-unquoted-performance-rights?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AMZA","TOLZ","DRLL","DIG","HIPS","PPI","WEEI","XES","XLEI","ALTY","EINC","AMLP","ENFR","BKGI","IQRA","FTXN","VDE","MDIV","UMI","EIPI","ERX","DRIP","USAI","PXJ","DBE","PXE","NFRA","RIFR","GLIX","ABLD","VRAI","EIPX","WTIU","MLPB","NFRX","DIV","TBG","GUSH","NML","ASET","DBC","GII","AMLX","MLPR","IEO","USE","IXC","IGF","DFRA","HALX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680768244","title":"Amylyx Pharmaceuticals Schedules Third-Quarter Results Release","url":"https://stock-news.laohu8.com/highlight/detail?id=2680768244","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680768244?lang=en_us&edition=fundamental","pubTime":"2026-11-02 22:01","pubTimestamp":1793628090,"startTime":"0","endTime":"0","summary":"Amylyx Pharmaceuticals Schedules Third-Quarter Results ReleaseAmylyx Pharmaceuticals will report third-quarter 2026 financial results on Nov. 5, 2026.Management will host a conference call and audio w","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261102:nNDL2wdj8P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMLX","LU0889565916.HKD","BK4007","LU0109394709.USD","LU0053671581.USD","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679268604","title":"Vmoto strikes European fleet partnership with Mute Group","url":"https://stock-news.laohu8.com/highlight/detail?id=2679268604","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2679268604?lang=en_us&edition=fundamental","pubTime":"2026-10-30 12:17","pubTimestamp":1793333845,"startTime":"0","endTime":"0","summary":"Vmoto Limited ( ($AU:VMT) ) has provided an announcement. Vmoto has entered a strategic fleet supply and energy infrastructure partnership with the...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vmoto-strikes-european-fleet-partnership-with-mute-group?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vmoto-strikes-european-fleet-partnership-with-mute-group?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MLPI","RIFR","BK4007","NFRX","UMI","HALX","LU0889565916.HKD","WEEI","EPV","USAI","HIPS","ENFR","EINC","PPI","DFRA","NML","ALTY","MLPB","VRAI","LU0320765992.SGD","BK4585","NFRA","BK4570","ABLD","AMLP","MLPR","ASET","DIV","IQRA","MDIV","GII","TBG","GARA","XLEI","AMZA","LU0053671581.USD","TOLZ","AMLX","IGF","EIPX","IMLP","EIPI","MLPY","GLIX","BK4588","BKGI","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679776984","title":"Amylyx Pharmaceuticals, Inc. : Mizuho Cuts Target Price to $38 from $42","url":"https://stock-news.laohu8.com/highlight/detail?id=2679776984","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2679776984?lang=en_us&edition=fundamental","pubTime":"2026-10-29 18:38","pubTimestamp":1793270334,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261029:nFWN46F1Z4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","LU0053671581.USD","LU0889565916.HKD","LU0109394709.USD","LU0320765992.SGD","AMLX"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.amylyx.com","stockEarnings":[{"period":"1week","weight":0.0586},{"period":"1month","weight":0.0984},{"period":"3month","weight":0.3238},{"period":"6month","weight":1.2269},{"period":"1year","weight":1.5378},{"period":"ytd","weight":1.5588}],"compareEarnings":[{"period":"1week","weight":-0.0059},{"period":"1month","weight":-0.0368},{"period":"3month","weight":-0.0292},{"period":"6month","weight":0.0023},{"period":"1year","weight":0.1005},{"period":"ytd","weight":0.0997}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Amylyx Pharmaceuticals, Inc., a commercial-stage biotechnology company, engages in the discovery and development of treatment for amyotrophic lateral sclerosis (ALS) and neurodegenerative diseases. The company's products include RELYVRIO, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment of ALS in adults in the United States and marketed as ALBRIOZA for the treatment of ALS in Canada. It is also developing AMX0114 for other neurodegenerative diseases. Amylyx Pharmaceuticals, Inc. was founded in 2013 and is headquartered in Cambridge, Massachusetts.","yearOnYearQuotes":[{"month":1,"riseRate":0.75,"avgChangeRate":0.074034},{"month":2,"riseRate":0.6,"avgChangeRate":0.089231},{"month":3,"riseRate":0.2,"avgChangeRate":-0.324118},{"month":4,"riseRate":0.4,"avgChangeRate":-0.019949},{"month":5,"riseRate":0.2,"avgChangeRate":-0.057575},{"month":6,"riseRate":0.8,"avgChangeRate":0.328198},{"month":7,"riseRate":1,"avgChangeRate":0.191259},{"month":8,"riseRate":0.6,"avgChangeRate":0.152419},{"month":9,"riseRate":0.6,"avgChangeRate":0.147012},{"month":10,"riseRate":0.6,"avgChangeRate":0.16827},{"month":11,"riseRate":0.8,"avgChangeRate":0.023242},{"month":12,"riseRate":0.25,"avgChangeRate":-0.127185}],"exchange":"NASDAQ","name":"Amylyx Pharmaceuticals","nameEN":"Amylyx Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Amylyx Pharmaceuticals(AMLX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Amylyx Pharmaceuticals(AMLX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Amylyx Pharmaceuticals,AMLX,Amylyx Pharmaceuticals股票,Amylyx Pharmaceuticals股票老虎,Amylyx Pharmaceuticals股票老虎国际,Amylyx Pharmaceuticals行情,Amylyx Pharmaceuticals股票行情,Amylyx Pharmaceuticals股价,Amylyx Pharmaceuticals股市,Amylyx Pharmaceuticals股票价格,Amylyx Pharmaceuticals股票交易,Amylyx Pharmaceuticals股票购买,Amylyx Pharmaceuticals股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Amylyx Pharmaceuticals(AMLX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Amylyx Pharmaceuticals(AMLX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}